Improving outcomes in acute coronary sydromes - The FRISC II trial

Clinical Cardiology

Volumn 24, Issue 3 SUPPL., 2001, Pages

  Kontny, F ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute coronary syndrome; Dalteparin; Invasive management; Low molecular weight herapin; Myocardial infarction; Noninvasive management; Revascularization; Unstable coronary artery disease

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTICOAGULANT THERAPY; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

EID: 0035115411     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive compared with a conservative management strategy
2. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction
3. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST-segment elevation. Recommendations of the Task Force of the European Society of Cardiology
4. Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: A meta-analysis
5. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis
6. Reactivation of the coagulation system: Rationale for long-term antithrombotic treatment
7. Long-term low molecular mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
8. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
9. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary artery disease: The FRISC II invasive randomised trial
10. Acute management - How should we intervene?
11. Effects on mortality of long-term treatment with l.m.w. heparin in relation to troponin T level and ECG findings - A FRISC-2 substudy